Lobbying Information
Subject Matters
- Aboriginal Affairs
- Arts and Culture
- Budget
- Economic Development
- Employment and Training
- Health
- Industry
- Intellectual Property
- Internal Trade
- International Development
- International Relations
- International Trade
- Regional Development
- Research and Development
- Science and Technology
Subject Matter Details
Policies or Program
- Advocate for the establishment of public-private partnerships to support chronic disease prevention.
- Advocate for the implementation of a federal diabetes and obesity strategy.
- Support the establishment of a life sciences strategy in Canada
Regulation
- Communication around existing drug shortages and shared solutions to mitigate the impact on Canadians
Communication Techniques
-
Written communication
-
Oral communication
Government Institutions
-
Agriculture and Agri-Food Canada (AAFC)
-
Canada Foundation for Innovation
-
Canadian Heritage (PCH)
-
Canadian Human Rights Tribunal (CHRT)
-
Canadian Institutes of Health Research (CIHR)
-
Employment and Social Development Canada (ESDC)
-
Finance Canada (FIN)
-
Global Affairs Canada (GAC)
-
Health Canada (HC)
-
House of Commons
-
Indigenous Services Canada (ISC)
-
Innovation, Science and Economic Development Canada (ISED)
-
National Research Council (NRC)
-
Parks Canada (PC)
-
Patented Medicine Prices Review Board (PMPRB)
-
Prime Minister's Office (PMO)
-
Privy Council Office (PCO)
-
Public Health Agency of Canada (PHAC)
-
Senate of Canada
-
Treasury Board Of Canada Secretariat (TBS)
In-house Organization Details
Description of the organization's activities
Novo Nordisk is a leading global healthcare company, founded in 1923 and headquartered in Denmark. Our purpose is to drive change to defeat diabetes and other serious chronic diseases such as obesity and rare blood and endocrine disorders. We do so by pioneering scientific breakthroughs, expanding access to our medicines, and working to prevent and ultimately cure disease.
Responsible officer name and position during the period of this registration
Vince Lamanna,
President
Organization's membership or classes of membership
Novo Nordisk employs about 57,100 people in 80 countries and markets its products in around 170 countries.
Government funding
No government funding was received during the last completed financial year.
In-house Organization Contact Information
Address:
101-2476 Argentia Road
Mississauga, ON L5N 6M1
Canada
Telephone number:
905-629-4222
Lobbyists Details
Employees who lobby for the organization
- Gabrielle Berard,
Senior Manager, External Affairs |
Designated public offices held
- Michael Tucker,
Patient Access Manager, Atlantic |
No public offices held
